Decipher Labs Stock Screener | Share Price & Fundamental Analysis

Share Price BSE
₹5.92
▼ -1.48 (-20.00%)
2026-03-02 00:00:00
Track Decipher Labs share price live with TickJournal's free stock screener. Analyze Decipher Labs share price history trends and compare 52-week high low levels. Calculate DECIPHER stock fair value using fundamental analysis and view live share price charts. Determine Decipher Labs share intrinsic value and compare it with current DECIPHER share price. Record your Decipher Labs trades in TickJournal's free trading journal and track your portfolio performance.
EPS (TTM) ₹-5.03
Dividend Yield -
Debt to Equity 0.01
Decipher Labs 52 Week Low ₹5.92
Operating Margin -188.00%
Profit Margin -100.00%
EBITDA ₹-6.00
Net Income ₹-4.00
Total Assets ₹26.00
Total Equity ₹23.00

Decipher Labs Share Price History - Stock Screener Chart

Screen DECIPHER historical share price movements with interactive charts. Analyze price trends and patterns.

Decipher Labs Company Profile - Fundamental Screener

Screen Decipher Labs company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for DECIPHER shares.
Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E
ISIN INE643N01012

Decipher Labs Balance Sheet Screener

Screen DECIPHER balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023 2022 2021 2020 2019 2018
Assets
Total Assets 26 34 28 42 39 35 6 3
Current Assets 21 25 20 38 23 23 6 3
Fixed Assets 3 3 3 3 4 5 0 0
Liabilities
Total Liabilities 26 34 28 42 39 35 6 3
Current Liabilities 0 0 0 7 8 2 0 0
Non-Current Liabilities 0 0 0 0 0 0 0 0
Shareholders' Equity
Total Equity 23 22 23 24 14 13 3 2
Share Capital 10 10 10 10 10 10 8 8
Reserves & Surplus 13 12 13 14 4 3 -6 -6

Decipher Labs Income Statement Screener - Profit & Revenue Analysis

Screen Decipher Labs income statement and profit fundamentals. Analyze DECIPHER quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Decipher Labs share price evaluation.
Item 2025-Mar 2025-Jun 2025-Sept 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec 2022-Mar 2022-Jun 2022-Sept 2022-Dec
Revenue 4 3 4 11 8 6 6 10 10 8 8 24 20 15 9
Expenses 10 6 4 9 6 7 6 14 10 10 8 21 13 13 16
EBITDA -6 -3 0 2 2 -1 -1 -4 0 -2 0 3 6 2 -8
Operating Profit % -188.00% -114.00% 3.00% 11.00% 18.00% -23.00% -11.00% -39.00% -1.00% -29.00% 2.00% 11.00% -6.00% -7.00% -47.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax -6 -3 0 1 1 -1 -1 -4 0 -2 0 3 6 2 -8
Tax -2 0 0 0 0 0 0 0 1 0 0 1 0 0 0
Net Profit -4 -3 0 1 1 -1 -1 -4 -1 -2 0 2 6 1 -8
EPS -4.07 -3.39 0.02 1.19 0.94 -1.31 -0.59 -4.23 -0.94 -1.92 0.01 1.93 5.85 1.18 -7.68

Decipher Labs Cash Flow Screener - Liquidity Fundamentals

Screen DECIPHER cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March
Operating Activities -10 5 -2 8 2 -15 0 0
Investing Activities 3 -2 -4 -1 0 0 0 0
Financing Activities 0 -1 -2 1 4 16 0 0
Net Cash Flow -7 2 -8 8 6 1 0 0

Decipher Labs Shareholding Pattern Screener

See Decipher Labs shareholding pattern with promoter, FII, and DII holdings. Check Decipher Labs promoter holding and ownership changes for DECIPHER on TickJournal.
Item 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-Mar 2023-Dec
Promoter Holding 16.43% 16.43% 16.43% 16.43% 16.43% 16.43% 16.43% 16.43%
FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 78.73% 78.76% 80.75% 80.73% 80.57% 80.52% 80.43% 80.50%
Other Holding 4.84% 4.81% 2.82% 2.84% 3.00% 3.05% 3.14% 3.07%
Shareholder Count 30,174 30,512 31,182 31,482 31,838 32,833 33,371 34,511

Decipher Labs Share Dividend Screener - Share Yield Analysis

Check Decipher Labs dividend history with payout and yield data. View Decipher Labs dividend details including ex-dates and amounts for DECIPHER stock.
No dividends declared by Decipher Labs.

Decipher Labs Stock Index Membership

See which indices include Decipher Labs stock. Check DECIPHER index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Decipher Labs is not part of any tracked indices.
Only major market indices are tracked in our system.

Decipher Labs Market Events Screener - Corporate Actions

Get Decipher Labs corporate actions including splits, bonuses, and buybacks. Check Decipher Labs stock events that may affect DECIPHER share price.
Announcement Date Record Date Event Type Information Price Impact
Annual General Meeting NA -7.24%
Annual General Meeting NA 1.45%
2025-11-13 2025-11-13 Quarterly Result Announcement NA -5.53%
2025-08-14 2025-08-14 Quarterly Result Announcement NA -0.73%
2025-05-30 2025-05-30 Quarterly Result Announcement NA -1.91%
2025-02-13 2025-02-13 Quarterly Result Announcement NA -2.95%
2024-11-14 2024-11-14 Quarterly Result Announcement NA -3.57%
2020-02-12 2020-02-12 Change Of Name NA 0.00%

Decipher Labs Competitors Screener - Peer Comparison

Screen DECIPHER competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 424,634 39.93 54,729 9.71% 10,980 49.55
Divis Laboratories 172,860 69.20 9,712 18.67% 2,191 56.33
Torrent Pharmaceuticals 129,151 60.10 11,539 6.99% 1,911 61.47
Cipla 122,205 22.55 28,410 7.12% 5,291 49.47
Dr Reddys Laboratories 107,114 18.60 33,741 16.73% 5,725 60.05
Lupin 97,120 22.34 22,910 13.74% 3,306 65.28
Zydus Life Science 92,392 18.40 23,511 18.55% 4,615 40.07
Mankind Pharma 90,241 50.59 12,744 20.90% 2,007 45.53
Aurobindo Pharma 71,119 20.79 32,346 9.43% 3,484 59.88
Alkem Laboratories 67,243 27.59 13,458 3.70% 2,216 49.80

Decipher Labs Company Announcements - News Screener

Screen DECIPHER latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2025-11-13 Announcement under Regulation 30 (LODR)-Change in Management View
2025-11-13 Unaudited Financial Results For The Quarter And Half Year Ended 30.09.2025 View
2025-11-13 Board Meeting Outcome for Outcome Of The Board Meeting Held On 13.11.2025 View
2025-11-10 Board Meeting Intimation for 1. Un-Audited Financial Results And Limited Review Report (Standalone And Consolidated) For The Quarter And Half Year Ended September 30 2025. 2. Any Other Business With The Permission Of The Chair. View
2025-10-18 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 View
2025-09-30 Shareholder Meeting / Postal Ballot-Scrutinizers Report View
2025-09-30 Shareholder Meeting / Postal Ballot-Outcome of AGM View
2025-09-26 Closure of Trading Window View
2025-09-20 Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 View
2025-09-08 Intimation Of Book Closure And Cut-Off Date For The 39Th Annual General Meeting Of Decipher Labs Limited View
2025-09-08 Reg. 34 (1) Annual Report. View
2025-09-08 Annual General Meeting Will Be Held On 30.09.2025 View
2025-09-05 Announcement under Regulation 30 (LODR)-Change in Management View
2025-09-05 Board Meeting Outcome for Outcome Of Board Meeting Held On Friday 05Th September 2025. View
2025-08-14 Announcement under Regulation 30 (LODR)-Change in Management View
2025-08-14 Unaudited Financial Results For The Quarter Ended 30.06.2025 View
2025-08-14 Board Meeting Outcome for Outcome Of The Board Meeting Held On 14.08.2025 View
2025-08-12 Disclosure As Per Regulation 30 Of SEBI Listing Regulations 2015 View
2025-08-11 Board Meeting Intimation for Considering The Un-Audited Financial Results (Standalone And Consolidated) And Limited Review Report (Standalone And Consolidated) For The Quarter Ended June 30 2025 And Any Other Business With The Permission Of The Chair. View
2025-07-15 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 View